← Back to headlines
Raymond James Lowers Viking Therapeutics Price Target
Raymond James has lowered its price target for Viking Therapeutics, Inc. (VKTX), despite an optimistic outlook on the company's clinical initiatives.
4 Mar, 06:45 — 4 Mar, 06:45
Sources
Showing 1 of 1 sources
